Verve Therapeutics - Company Information
Verve therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. verve's gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower ldl cholesterol and triglyceride levels. the company is advancing a pipeline of precision genetic medicines, led by verve-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. in 2023, verve was recognized as a "best places to work" by the boston globe. verve is headquartered in boston, massachusetts.
Biotechnology
Verve Therapeutics - Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by Sprouts.ai, used by Verve Therapeutics.
Materialize
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Javascript
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Vue.js
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
TweenMax
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Polyfill
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
PHP
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Employee profile
John Doe
CEO
Samantha Duncan
CTO
Gary Austin
MD
Jonathan Shaw
CMD
Janice May
MD
Janet McDonald
CFO
Verve Therapeutics - Company Information
Verve therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. verve's gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower ldl cholesterol and triglyceride levels. the company is advancing a pipeline of precision genetic medicines, led by verve-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. in 2023, verve was recognized as a "best places to work" by the boston globe. verve is headquartered in boston, massachusetts.
Biotechnology
Verve Therapeutics - Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by Sprouts.ai, used by Verve Therapeutics.
Materialize
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Javascript
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Vue.js
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
TweenMax
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Polyfill
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
PHP
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Employee profile
John Doe
CEO
Samantha Duncan
CTO
Gary Austin
MD
Jonathan Shaw
CMD
Janice May
MD
Janet McDonald
CFO
